List of bibliographic references
Number of relevant bibliographic references: 20.
Ident. | Authors (with country if any) | Title |
---|
000776 (2012) |
O. Rascol [France] ; J. Bronzova ; R A Hauser ; A E Lang ; C. Sampaio ; A. Theeuwes ; S V Van De Witte | Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial. |
000926 (2011) |
Sylvia Navailles [France] ; Bernard Bioulac ; Christian Gross ; Philippe De Deurwaerdère | Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease. |
000A15 (2010) |
Olivier Rascol [France] ; Paolo Barone ; Robert A. Hauser ; Yoshikuni Mizuno ; Werner Poewe [Autriche] ; Anthony H V. Schapira ; Laurence Salin ; Mandy Sohr ; Catherine Debieuvre | Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease. |
000B56 (2008) |
Erwan Bezard [France] | [Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure]. |
000D12 (2007) |
G. Villafane [France] ; P. Cesaro ; A. Rialland ; S. Baloul ; S. Azimi ; C. Bourdet ; J. Le Houezec ; I. Macquin-Mavier ; P. Maison | Chronic high dose transdermal nicotine in Parkinson's disease: an open trial. |
000F33 (2004) |
S. Robelet [France] ; C. Melon ; B. Guillet ; P. Salin ; L. Kerkerian-Le Goff | Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease. |
000F54 (2003) |
S. Thobois [France] ; S. Corvaisier ; P. Mertens ; C. Di Guardo ; H. Mollion ; M. Guenot ; F. Rochefort ; G. Chazot ; M. Sindou ; E. Broussolle | The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulation. |
000F59 (2003) |
Olivier Rascol [France] ; C. Brefel-Courbon ; P. Payoux ; J. Ferreira | The management of patients with early Parkinson's disease. |
000F85 (2003) |
Olivier Rascol [France] | Monoamine oxidase inhibitors--is it time to up the TEMPO? |
001002 (2003) |
Marc Ziegler [France] ; Alexandre Castro-Caldas ; Susanna Del Signore ; Olivier Rascol | Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study. |
001008 (2003) |
H. Mollion [France] ; J. Ventre-Dominey ; P F Dominey ; E. Broussolle | Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease. |
001084 (2002) |
Aïcha Douhou [France] ; Thomas Debeir ; Mario Gustavo Murer ; Louis Do ; Noëlle Dufour ; Véronique Blanchard ; Saliha Moussaoui ; Georg Andrees Bohme ; Yves Agid [France] ; Rita Raisman-Vozari | Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice. |
001142 (2001) |
F. Durif [France] ; I. Devaux ; J J Pere ; J C Delumeau ; I. Bourdeix | Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study. |
001274 (1999) |
Yves Agid [France] ; E. Ahlskog ; A. Albanese ; D. Calne ; T. Chase ; J. De Yebenes ; S. Factor ; S. Fahn ; O. Gershanik ; C. Goetz ; W. Koller ; M. Kurth ; A. Lang ; A. Lees ; P. Lewitt ; D. Marsden ; E. Melamed ; P P Michel ; Y. Mizuno ; J. Obeso ; W. Oertel ; W. Olanow ; Werner Poewe [Autriche] ; P. Pollak ; E. Tolosa | Levodopa in the treatment of Parkinson's disease: a consensus meeting. |
001406 (1997) |
E. Bezard [France] ; S. Dovero ; B. Bioulac ; C. Gross | Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. |
001505 (1995) |
P. Limousin [France] ; P. Pollak ; J P Pfefen ; C L Tournier-Gervason ; R. Dubuis ; J E Perret | Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, Parkinson's disease. |
001532 (1994) |
R. Marconi [France] ; D. Lefebvre-Caparros ; A M Bonnet ; M. Vidailhet ; B. Dubois ; Yves Agid [France] | Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. |
001571 (1993) |
E. Nicolle [France] ; P. Pollak ; F. Serre-Debeauvais ; P. Richard ; C L Gervason ; E. Broussolle ; M. Gavend | Pharmacokinetics of apomorphine in parkinsonian patients. |
001627 (1992) |
A P Feve [France] ; N. Bathien ; P. Rondot | Chronic administration of L-dopa affects the movement-related cortical potentials of patients with Parkinson's disease. |
001799 (????) |
O. Rascol [France] ; D J Brooks ; E. Melamed ; W. Oertel ; Werner Poewe ; F. Stocchi ; E. Tolosa | Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Drug Administration Schedule"
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i \
-Sk "Drug Administration Schedule" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Checkpoint
|type= indexItem
|index= Mesh.i
|clé= Drug Administration Schedule
}}
| This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 | |